, confirmed that a plant-derived compound termed conolidine may well operate to improve opioid peptides’ agony-regulating exercise, suggesting that it may be a safer option to opioid medicines. On top of that, the conolidine molecule didn't interact with the classical receptors, meaning that it would not compete against opioid https://chronic-pain-why-prolevia38394.jiliblog.com/86646983/fascination-about-conolidine